Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Clearside Biomedical Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CLSD
Nasdaq
8731
https://clearsidebio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Clearside Biomedical Inc
Q1 2024 Clearside Biomedical Inc Earnings Call
- May 10th, 2024 6:15 pm
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript
- May 10th, 2024 3:56 pm
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
- May 9th, 2024 10:55 pm
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
- May 9th, 2024 8:05 pm
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
- May 8th, 2024 8:15 pm
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024
- Apr 30th, 2024 11:05 am
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
- Apr 16th, 2024 11:05 am
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 2nd, 2024 11:05 am
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
- Mar 18th, 2024 11:05 am
Clearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
- Mar 14th, 2024 10:18 am
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript
- Mar 13th, 2024 12:30 pm
Q4 2023 Clearside Biomedical Inc Earnings Call
- Mar 13th, 2024 10:38 am
Clearside Biomedical Inc (CLSD) Reports Significant Licensing Revenue Growth in Q4 and Full ...
- Mar 12th, 2024 9:35 pm
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Mar 12th, 2024 8:05 pm
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 200%, Say Analysts
- Mar 6th, 2024 7:25 pm
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024
- Feb 29th, 2024 12:05 pm
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
- Feb 25th, 2024 6:37 pm
Pleasing Signs As A Number Of Insiders Buy Clearside Biomedical Stock
- Feb 9th, 2024 10:54 am
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
- Feb 7th, 2024 1:00 pm
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
- Dec 14th, 2023 12:05 pm
Scroll